Le Lézard
Classified in: Environment, Health
Subject: RCY

Bausch + Lomb Helps To Recycle More Than One Million Units Of Contact Lens Materials Within First Year Of Launching The ONE By ONE Recycling Program


First Sponsored Contact Lens Recycling Program Collects More Than 7,000 lbs. of Waste

LAVAL, Quebec, Nov. 15, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.'s (NYSE: VRX and TSX: VRX) wholly owned subsidiary, Bausch + Lomb, today announced that its unique ONE by ONE Recycling Program has recycled a combined total of more than one million used contact lenses, blister packs and top foils in less than one year since its launch. Made possible through a collaboration with TerraCycle®, a world leader in the collection and repurposing of hard-to-recycle post-consumer waste, the ONE by ONE Recycling Program has diverted more than 7,000 pounds of waste from landfills.

In addition, for every pound of accepted packaging received through this program, a $1 donation is made to Optometry Giving Sight, the only global fundraising initiative that specifically targets the prevention of blindness and impaired vision by providing eye exams and glasses to those in need.

"We are globally committed to environmental sustainability while also delivering innovations that meet the needs of our physicians and their patients," said Joseph C. Papa, chairman and CEO, Valeant. "We are proud of the ONE by ONE Recycling Program, which has made significant strides in its first year by helping to reduce contact lens waste as well as helping to provide basic vision care to those who are in need."

Although contact lenses and their packaging are generally composed of recyclable plastic or foil, they often end up being filtered out of most standard recycling centers due to their small size. Currently, the end-to-end trail of waste generated from contact lens packaging annually in the United States could circle the earth three times. The ONE by ONE Recycling Program provides contact lens wearers the opportunity to properly recycle their used materials and reduce the amount of waste deposited to landfills across the country. 

To participate in the program, contact lens wearers can print a free ONE by ONE shipping label and ship their used blister packs, top foil and contact lenses via any UPS location or drop off their waste at a participating eye doctor's office. All participating offices in the United States (more than 2,000 to date) can be found on the program's website, www.bauschrecycles.com.

About Bausch + Lomb
Bausch + Lomb, a Valeant Pharmaceuticals International, Inc. company, is a leading global eye health organization that is solely focused on protecting, enhancing and restoring people's eyesight. Our core businesses include over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry, which is available in more than 100 countries.

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

Forward-looking Statements
This press release may contain forward-looking statements which may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in the Company's most recent annual or quarterly report and detailed from time to time in Valeant's other filings with the Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Valeant undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes, unless required by law.

Investor Contact:

Media Contact:

Arthur Shannon

Lainie Keller

[email protected]

[email protected]

(514) 856-3855

(908) 927-0617

(877) 281-6642 (toll free)


 

Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.) (PRNewsFoto/)

 

SOURCE Valeant Pharmaceuticals International, Inc.


These press releases may also interest you

at 15:00
Drax Group, a pioneer in carbon removal and renewable energy, has formed a groundbreaking partnership with environmental leader Karbon-X , marking a significant advancement in the deployment of Bioenergy with Carbon Capture and Storage (BECCS)...

at 14:50
The American Water Charitable Foundation, a 501(c)(3) organization established by American Water, the largest regulated water and wastewater utility company in the U.S., announced today that it has donated $250,000 to the American Red Cross as a new...

at 14:30
Southwest Airlines Co.  announces the acquisition of SAFFiRE Renewables, LLC (SAFFiRE) as part of the investment portfolio of its wholly owned subsidiary Southwest Airlines Renewable Ventures, LLC (SARV). SARV is dedicated to creating more...

at 13:15
The American Society of Interior Designers (ASID), in collaboration with the Chemical Insights Research Institute (CIRI) of UL Research Institutes, unveiled new research today on the effects of extreme weather and climate events on the built...

at 12:50
Global sales of electric vehicles (EVs) increased from 716,000 vehicles in 2015 to 10.6 million vehicles in 2022. Meanwhile, demand rose for the materials used in EV batteries such as graphite, cobalt and lithium. As demand jumps for these critical...

at 12:30
Aardex, a data-driven, community-minded real estate investment and development firm that has built out more than 1.5 million square feet of projects over the last 40 years, today announced the launch of a new company, Stellera, which will focus on...



News published on and distributed by: